Cover
Cover | May 13, 2022 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | On May 18, 2022, 22nd Century Group, Inc. (the “Company”), filed with the U.S. Securities and Exchange Commission a Current Report on Form 8-K (the Original Form 8-K) regarding the completion of the Companys acquisition, on May 13, 2022, of substantially all of the assets of GVB Biopharmas (GVB) business dedicated to hemp-based cannabinoid extraction, refinement, contract manufacturing and product development (the Transaction). |
Document Period End Date | May 13, 2022 |
Entity File Number | 001-36338 |
Entity Registrant Name | 22nd Century Group, Inc. |
Entity Central Index Key | 0001347858 |
Entity Tax Identification Number | 98-0468420 |
Entity Incorporation, State or Country Code | NV |
Entity Address, Address Line One | 500 Seneca Street |
Entity Address, Address Line Two | Suite 507 |
Entity Address, City or Town | Buffalo |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 14204 |
City Area Code | 716 |
Local Phone Number | 270-1523 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.00001 par value |
Trading Symbol | XXII |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |